Cancer Immunothherapy

Cancer

Cells Of The Immune System

Immunity and Cancer

Immunotherapy For Cancer

Origin Of Idea: Dr William Coley

Immunotherapy: Unleashes the patient immune system

Global Cancer Immunotherapy Market Revenue

Monoclonal Antibodies: Major share of the market

 Tumour Specific Monoclonal Antibodies 

Magic Bullets To Clinical Reality

Herceptin: In September 1998 Trastuzumab (Herceptin) became the the first antibody approved for the treatment of a solid tumor.

Herceptin: Second monoclonal antibody approved for the treatment of a malignant condition.

Herceptin: First Humanised anti Her 2 monoclonal antibody

Herceptin: Mechanism Of Action

Cancer Immunotherapy

Monoclonal Antbodies ( Snapshot)